| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MACROGENICS INC | 3,168 | 120,000 | 0.02% | ||
| 2 | COLUCID PHARMACEUTICALS ORD | 21,806 | 194,000 | 0.03% | ||
| 3 | SANGAMO THERAPEUTICS INCORPORATED | 22,487 | 249,000 | 0.04% | ||
| 4 | ENTEROMEDICS INC | 1,113,168 | 690,000 | 0.12% | ||
| 5 | MAST THERAPEUTICS INC COM | 2,551,851 | 1,250,000 | 0.21% | ||
| 6 | CONATUS PHARMACEUTICALS INC | 1,192,080 | 6,139,000 | 1.03% | ||
| 7 | VERASTEM INC | 816,683 | 6,158,000 | 1.03% | ||
| 8 | TRIVASCULAR TECHNOLOGIES INC | 1,776,692 | 9,505,000 | 1.59% | ||
| 9 | PHARMATHENE INC COM | 6,347,614 | 11,426,000 | 1.91% | ||
| 10 | Proteon Therapeutics Inc | 983,381 | 17,563,000 | 2.94% | ||
| 11 | NEVRO CORP COM | 356,704 | 19,173,000 | 3.21% | ||
| 12 | ARATANA THERAPEUTICS INC | 2,118,845 | 32,037,000 | 5.36% | ||
| 13 | EPIZYME INC COM | 1,781,086 | 42,746,000 | 7.15% | ||
| 14 | PORTOLA PHARMACEUTICALS INC | 1,220,672 | 55,602,000 | 9.30% | ||
| 15 | RADIUS HEALTH INCORPORATED COM NEW | 5,831,253 | 394,776,000 | 66.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-007803, filed 2015.07.29).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
